Company intelligence / Profile preview

MABIO

Évry-Courcouronnes, Île-de-France, France

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Mabio is a French biotechnology company specializing in bioprocessing and bioproduction services for the life sciences industry. The company provides high-performance cell culture media, process development services, and customized bioproduction solutions designed to optimize the manufacture of monoclonal antibodies and recombinant proteins. Mabio focuses on bridging the gap between R&D and industrial-scale production by offering scalable technologies and expert consultancy. Their services are tailored to help biopharmaceutical companies improve yields and reduce time-to-market for complex biologics.

Modalities: Monoclonal antibodyRecombinant proteinCell therapy
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on MABIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MABIO.

Explore the full profile